Opioid Addiction Epidemic Lawsuits Pile Up

Thanksgiving is now behind us, and we hope you made it through the holiday drug and alcohol-free. At Celebrate Hope, we understand how challenging it is to navigate holidays in recovery. Every holiday celebrated clean and sober is a remarkable accomplishment worth acknowledging. 

 

We wanted to take a moment to follow up on a previous story covered recently on our blog regarding Purdue Pharma—the maker of OxyContin. As we shared in an article last month, Purdue agreed to plead guilty to criminal charges regarding its role in the American opioid addiction epidemic. As part of the settlement with the Justice Department, the pharmaceutical giant also agreed to face penalties of about $8.3 billion. 

 

Purdue pleaded guilty to the criminal charges two days before Thanksgiving, The New York Times reports. During the November 24th hearing, Purdue admitted to misleading the federal government about OxyContin sales. 

 

Purdue’s chairman, Steve Miller, conceded that the company was marketing the potent narcotic to over 100 physicians suspected of illegally prescribing the drug. What’s more, Purdue pleaded guilty to paying doctors illegal kickbacks for prescribing OxyContin. Thus concludes the federal government’s case against the pharmaceutical company.  

“The abuse and diversion of prescription opioids has contributed to a national tragedy of addiction and deaths,” said Jeffrey A. Rosen, the deputy attorney general. “Today’s convictions underscore the department’s commitment to its multipronged strategy for defeating the opioid crisis.” 

 

We want to remind our readers that there are thousands of pending lawsuits against Purdue. Purdue’s guilty plea does not shield the company from the suits brought by state and local governments. Moreover, Purdue is just one company that contributed to the opioid epidemic; many companies had a hand in the more than 450,000 American deaths since 1999. 

 

Many Players Involved in the Opioid Addiction Epidemic

 

Just as Purdue turned a blind eye to the devastation caused by OxyContin, so too did other narcotic makers and the companies that distribute such drugs. Pharmacies and the companies that distribute to them are also facing thousands of lawsuits. 

 

Johnson & Johnson and three drug distributors are hashing out a $26 billion deal with state and local governments for their hand in the opioid addiction epidemic, according to The New York Times. The distributors involved in the negotiations are McKesson, Cardinal Health, AmerisourceBergen. If an agreement is reached, it will shield the four companies from future lawsuits by these governments. 

 

Prescription opioids had a hand in more than 232,000 American deaths from 1999 to 2018, according to the Centers for Disease Control and Prevention. More than three-quarters of the nation’s opioids shipped to pharmacies came from the three distributors listed above, the article reports. If approved by the governments involved in the lawsuits, most of the $26 billion would go towards treatment and prevention in areas severely impacted by opioids. 

 

“The deal gets money to all of the communities in the United States that are suffering from insult upon injury, first from the opioid epidemic and now with COVID as well,” said Paul J. Hanly Jr., an attorney who represents numerous small governments. “We believe it’s in the best interest of these communities to begin receiving a payment stream. We looked at the finances of these companies and believe the numbers are now appropriate.”

 

California Faith-Based Addiction Treatment

 

If you or a loved one struggles with opioid use disorder, please contact Celebrate Hope to learn more about our faith-based addiction treatment program. Our team helps men and women break the cycle of addiction and begin anew. We rely on the teachings of Jesus Christ, along with evidence-based therapies to get individuals on the path of recovery.

OxyContin and Opioid Epidemic Settlement

When discussing the American opioid addiction epidemic, the name OxyContin is synonymous. The brand name of oxycodone, a powerful prescription opioid, is closely associated with our toxic relationship with painkillers in the United States. 

 

Even people who've never been prescribed an opioid are familiar with OxyContin. The drug was prescribed by doctors in large amounts from the mid-nineties onward. The drugmaker – Purdue Pharma – marketed OxyContin as safe for users; the company contended that it carried a low risk of addiction. 

 

Now 25 years later and tens of thousands of overdose deaths, OxyContin is anything but safe when prescribed in high doses for protracted periods. What's more, most of today's heroin users were introduced to opioids via drugs like oxycodone. Around 80 percent of people using heroin started down the path of opioid use disorder with prescription painkillers. 

 

In recent years, the prescription drug industry or "big pharma" has been asked to account for its role in creating the public health crisis we face today. From doctors to drug distributors to the makers of the drugs themselves, many entities are in the hot seat for the more than 450,000 Americans who have died from an overdose since 1999. 

 

While heroin and illicit fentanyl – a drug 100 times more potent than morphine – dominate the headlines today, the epidemic's origin goes back to rampant overprescribing dating back to the 1990s. According to the Centers for Disease Control and Prevention (CDC), many doctors continue to prescribe high doses of oxycodone across the country more than two decades later. 

 

In 2017, there were still almost 58 opioid prescriptions written for every 100 Americans; more than 17% of Americans had at least one opioid medication filled. More than 191 million opioid prescriptions were dispensed to Americans that year. 

 

OxyContin Maker Held Accountable

 

Last month, the U.S Justice Department and Purdue Pharma agreed regarding its role in the opioid epidemic. The pharmaceutical giant agreed to plead guilty to criminal charges and face penalties of around $8.3 billion, The New York Times reports. Members of the Sackler family – the owners of Purdue Pharma – agreed to pay $225 million in civil penalties. 

 

Purdue will plead guilty to felony charges of defrauding federal health agencies and violating anti-kickback laws, according to the article. The company will be ordered to pay $3.54 billion in criminal fines, $2.8 billion in civil penalties for violating the False Claims Act, and $2 billion in criminal forfeiture of profits. 

 

It's worth noting that there are thousands of pending lawsuits against Purdue Pharma. The agreement with the justice department could pave the way to a resolution in many of those cases. Steve Miller, chairman of the company board, said: 

 

"Purdue deeply regrets and accepts responsibility for the misconduct detailed by the Department of Justice in the agreed statement of facts." 

 

While more than $8 billion is a lot of money, there is little indication that the company will pay anything close to that because it filed for bankruptcy court protection when the lawsuits started piling up. What's more, there are some who feel that the agreement does not go far enough even though it did not preclude the filing of criminal charges against Purdue executives or members of the Sackler family. Maura Healey, the Massachusetts attorney general, said: 

 

"The D.O.J. failed. Justice in this case requires exposing the truth and holding the perpetrators accountable, not rushing a settlement to beat an election. I am not done with Purdue and the Sacklers, and I will never sell out the families who have been calling for justice for so long." 

 

Massachusetts is moving forward with depositions against the Sacklers this month. It will be interesting to see how the cases against Purdue Pharma plays out. It could set a precedent; it is not the only company facing lawsuits for impropriety related to prescription opioids. 

 

Opioid Use Disorder Treatment

 

Please reach out to Celebrate Hope if you are struggling with prescription opioid or heroin addiction. We can help you break the cycle of addiction and get on the path toward healing. Opioid use disorder is treatable and recovery is possible

Enough Fentanyl to Kill 26 Million People

Opioid use disorder is a treatable mental illness; those who undergo treatment and commit themselves to working a program of recovery can lead productive lives. While useful forms of treatment are available, many find it difficult to seek help due to the intense cravings typical of opioid addiction. Everything that public health officials can do, must be done, to encourage as many people as possible to seek addiction treatment—the risk of overdose death is notoriously high.

Many of you are probably aware that the likelihood of fentanyl exposure among heroin addicts is exceedingly high. With each year that passes, more and more people succumb to fentanyl exposure, an analgesic that is 100 times more potent than morphine and 50-80 times stronger than average batches of heroin. When people cut heroin with fentanyl, the result is a deadly cocktail. In fact, research shows that fentanyl-related deaths more than tripled between 2010 and 2016.

One of the reasons fentanyl is more prevalent than ever is because cartels in Mexico can synthesize the drug with ease. Drug cartels acquire the necessary precursors from Asia and then chemists south of the border manufacture the hazardous substance. Once in powder form, the drugs is either stamped into pills disguised as highly coveted OxyContin or cut into batches of heroin to boost potency. In either case, opioid users on this side of the border have no way of knowing that the drug they are about to ingest, smoke, snort, or inject contains the presence of fentanyl.

Fentanyl is Everywhere

So just how likely is it that people will come in contact with fentanyl? Highly likely! The drug made the headline once again after a Nebraska State Trooper pulled over a truck hauling 118 pounds of the deadly substance, CNN reports. The U.S. Drug Enforcement Administration (DEA) states that 2 milligrams of fentanyl is a lethal dose; a little math shows that there was enough fentanyl confiscated to kill roughly 26 million people.

"This year is going to be a banner year, a record year in a bad way, in overdose deaths in the United States," said Matthew Barden, an associate special agent with the ‎DEA.

Naloxone is a drug that can reverse the deadly symptoms of an overdose; unfortunately, fentanyl is so potent that it often doesn’t work and people die. When a fentanyl overdose is reversed, first responders often have to give victims multiple doses of the drug. Pharmacies sell naloxone under the name Narcan. Fentanyl is only going to be more prevalent in the coming years. Anyone caught in the destructive cycle of opioid use disorder should seek help immediately and begin working a program of addiction recovery.

 

Southern California Opioid Use Disorder Treatment

Celebrate Hope at Hope By The Sea can assist anyone struggling with an opioid use disorder. We can help you end the cycle of addiction, please contact us today.

Fentanyl Salesmen Arrested for Kickback to Doctors

An aspect of the prescription opioid epidemic that is often ignored is the role of pharmaceutical salesmen. These are people who are employed by pharmaceutical companies to travel around the country enticing doctors to prescribe their medical product. Now, it stands to reason that a physician's willingness to prescribe a drug should be based off of the drug's effectiveness at treating a specific condition—and in a perfect world that may be the case. However, doctors are often times given huge incentives to prescribe one medication over another, a practice which surely had a hand in the rampant over prescribing of drugs like OxyContin (oxycodone).

In the wake of the beloved pop star Prince’s death, attention has been redirected back to the powerful opioid analgesic fentanyl. Many Americans may have never heard of fentanyl as the drug is not commonly used outside of hospital settings. Those who had heard of the drug before may have been unaware that fentanyl is 100 time more potent than morphine. Fentanyl, while fast acting and highly effective, can cause severe respiratory depression that can be fatal; this is why it should be scarcely used except under the close supervision of doctors and nurses.

In an attempt to stem the tide of irresponsible prescribing practices, law enforcement has begun to set their sights on pharmaceutical salesmen. Recently, two former pharmaceutical salesmen were arrested from charges stemming from paying doctors to prescribe a form of fentanyl, USA Today reports. The two salesmen, who worked for Insys Therapeutics, allegedly paid two doctors in the New York-area $259,000 in kickbacks to prescribe Subsys.

Most fentanyl prescribed for take home use comes in the form a transdermal patch. The patches are adhered to one’s skin—slowly releasing the drug throughout the course of the day. Subsys, on the other hand, is sprayed under the tongue, according to the article. The spray version of fentanyl works quickly, relieving pain in just five minutes.

"You have this hyper-powerful drug marketed intensely, aggressively and shamelessly without any sense of the addictive and lethal power of what is being sold," said Arthur Caplan, the director of medical ethics at NYU Langone Medical Center in New York.

We will continue to follow the fentanyl story. Stay tuned.